Publication Cover
Neurocase
Behavior, Cognition and Neuroscience
Volume 23, 2017 - Issue 1
240
Views
6
CrossRef citations to date
0
Altmetric
Articles

Neuroversion: using electroconvulsive therapy as a bridge to deep brain stimulation implantation

, , , , , & show all
Pages 26-30 | Received 25 Dec 2015, Accepted 20 Dec 2016, Published online: 07 Feb 2017

References

  • Albanese, A., Piacentini, S., Romito, L. M. A., Leone, M., Franzini, A., Broggi, G., et al. (2005). Suicide after successful deep brain stimulation for movement disorders. Neurology, 65, 499–499. doi:10.1212/WNL.65.3.499
  • Andersen, K., Balldin, J., Gottfries, C. G., Granerus, A. K., Modigh, K., Svennerholm, L., et al. (1987). A double-blind evaluation of electroconvulsive therapy in Parkinson’s disease with “on-off” phenomena. Acta Neurologica Scandinavica, 76, 191–199. doi:10.1111/j.1600-0404.1987.tb03566.x
  • Arun, M. P., Bharath, S., Pal, P. K., & Singh, G. (2011). Relationship of depression, disability, and quality of life in Parkinson’s disease: A hospital-based case-control study. Neurology India, 59, 185–189. doi:10.4103/0028-3886.79133
  • Balldin, J., Eden, S., Granerus, A. K., Modigh, K., Svanborg, A., Walinder, J., et al. (1980). Electroconvulsive therapy in Parkinson’s syndrome with “on-off” phenomenon. Journal of Neural Transmission, 47, 11–21. doi:10.1007/BF01256635
  • Ducharme, S., Flaherty, A. W., Seiner, S. J., Dougherty, D. D., & Morales, O. G. (2011). Temporary interruption of deep brain stimulation for Parkinson’s disease during outpatient electroconvulsive therapy for major depression: A novel treatment strategy. The Journal of Neuropsychiatry and Clinical Neurosciences, 23, 194–197. doi:10.1176/jnp.23.2.jnp194
  • Fall, P. A., Ekman, R., Granerus, A. K., Thorell, L. H., & Walinder, J. (1995). ECT in Parkinson’s disease. Changes in motor symptoms, monoamine metabolites and neuropeptides. Journal of Neural Transmission – Parkinson’s Diseases and Dementia Section, 10, 129–140. doi:10.1007/BF02251228
  • Figiel, G. S., Hassen, M. A., Zorumski, C., Krishnan, K. R., Doraiswamy, P. M., Jarvis, M. R., et al. (1991). ECT-induced delirium in depressed patients with Parkinson’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 3, 405–411. doi:10.1176/jnp.3.4.405
  • Hurwitz, T. A., Calne, D. B., & Waterman, K. (1988). Treatment of dopaminomimetic psychosis in Parkinson’s disease with electroconvulsive therapy. The Canadian Journal of Neurological Sciences, 15, 32–34. doi:10.1017/S0317167100027141
  • Kamel, H., Cornes, S. B., Hegde, M., Hall, S. E., & Josephson, S. A. (2010). Electroconvulsive therapy for refractory status epilepticus: A case series. Neurocrit Care, 12, 204–210. doi:10.1007/s12028-009-9288-7
  • Kennedy, R., Mittal, D., & O’Jile, J. (2003). Electroconvulsive therapy in movement disorders: An update. The Journal of Neuropsychiatry and Clinical Neurosciences, 15, 407–421. doi:10.1176/jnp.15.4.407
  • Klein, H. U., Meltendorf, U., Reek, S., Smid, J., Kuss, S., Cygankiewicz, I., et al. (2010). Bridging a temporary high risk of sudden arrhythmic death. Experience with the Wearable Cardioverter Defibrillator (WCD). Pace-Pacing and Clinical Electrophysiology, 33, 353–367. doi:10.1111/j.1540-8159.2009.02590.x
  • Lilleeng, B., & Dietrichs, E. (2008). Unmasking psychiatric symptoms after STN deep brain stimulation in Parkinson’s disease. Acta Neurologica Scandinavica. Supplementum, 117, 41–45. doi:10.1111/j.1600-0404.2008.01030.x
  • Little, J. D. (2015). Attitudes toward electroconvulsive therapy compared with cardioversion. The Journal of ECT, 31, 179–181. doi:10.1097/yct.0000000000000211
  • Maile, S., Kunz, M., Oechslin, E., Zund, G., Rahn, M., Lachat, M. L., et al. (2004). Intractable ventricular tachycardia and bridging to heart transplantation with a non-pulsatile flow assist device in a patient with isolated left-ventricular non-compaction. The Journal of Heart and Lung Transplantation, 23, 147–149. doi:10.1016/s1053-2498(03)00101-3
  • Mortier, P., Sienaert, P., & Bouckaert, F. (2013). Is electroconvulsive therapy safe in the presence of an intracranial metallic object?: Case report and review of the literature. The Journal of ECT, 29, 231–238. doi:10.1097/YCT.0b013e31827f137b
  • Nirenberg, M. J. (2013). Dopamine agonist withdrawal syndrome: Implications for patient care. Drugs Aging, 30, 587–592. doi:10.1007/s40266-013-0090-z
  • Okun, M. S. (2012). Deep-brain stimulation for Parkinson’s disease. [Review]. The New England Journal of Medicine, 367, 1529–1538. doi:10.1056/NEJMct1208070
  • Okun, M. S., Wu, S. S., Foote, K. D., Bowers, D., Gogna, S., Price, C., et al. (2011). Do stable patients with a premorbid depression history have a worse outcome after deep brain stimulation for Parkinson disease?. Neurosurgery, 69, 357–361. Discussion 360–351. doi:10.1227/NEU.0b013e3182160456
  • Pintor, L. P., Valldeoriola, F., Fernandez-Egea, E., Sanchez, R., Rami, L., Tolosa, E., et al. (2012). Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: A pilot study. The Journal of ECT, 28, 87–91. doi:10.1097/YCT.0b013e31823c98c0
  • Rasmussen, K., & Abrams, R. (1991). Treatment of Parkinson’s disease with electroconvulsive therapy. The Psychiatric Clinics of North America, 14, 925–933.
  • Rose, D., Wykes, T., Leese, M., Bindman, J., & Fleischmann, P. (2003). Patients’ perspectives on electroconvulsive therapy: Systematic review. British Medical Journal, 326, 1363–1365. doi:10.1136/bmj.326.7403.1363
  • Sackeim, H. A., Prudic, J., Nobler, M. S., Fitzsimons, L., Lisanby, S. H., Payne, N., et al. (2008). Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Brain Stimulation, 1, 71–83. doi:10.1016/j.brs.2008.03.001
  • Sartorius, N., Gaebel, W., Cleveland, H.-R., Stuart, H., Akiyama, T., Arboleda-Florez, J., et al. (2010). WPA guidance on how to combat stigmatization of psychiatry and psychiatrists. World Psychiatry, 9, 131–144. doi:10.1002/j.2051-5545.2010.tb00296.x
  • Usui, C., Hatta, K., Doi, N., Kubo, S., Kamigaichi, R., Nakanishi, A., et al. (2011). Improvements in both psychosis and motor signs in Parkinson’s disease, and changes in regional cerebral blood flow after electroconvulsive therapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35, 1704–1708. doi:10.1016/j.pnpbp.2011.05.003
  • Veazey, C., Aki, S. O., Cook, K. F., Lai, E. C., & Kunik, M. E. (2005). Prevalence and treatment of depression in Parkinson’s disease. The Journal of Neuropsychiatry and Clinical Neurosciences, 17, 310–323. doi:10.1176/appi.neuropsych.17.3.310
  • Weintraub, D., Duda, J. E., Carlson, K., Luo, P., Sagher, O., Stern, M., et al. (2013). Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson’s disease: Results from a randomised, controlled trial. Journal of Neurology, Neurosurgery & Psychiatry, 84, 1113–1118. doi:10.1136/jnnp-2012-304396
  • Widge, A. S., Agarwal, P., Giroux, M., Farris, S., Kimmel, R. J., & Hebb, A. O. (2013). Psychosis from subthalamic nucleus deep brain stimulator lesion effect. Surgical Neurology International, 4, 7. doi:10.4103/2152-7806.106265
  • Williams, N., Sahlem, G., Short, B., Jeffery, A., Burns, C., Williams, E., et al. (2014). Neuroversion: Using electroconvulsive therapy as a bridge to deep brain stimulation implantation. Journal of Neuropsychiatry and Clinical Neurosciences, 26, 21.
  • Williams, N. R., Bentzley, B. S., Sahlem, G. L., Pannu, J., Korte, J. E., & Revuelta, G., et al. (2016). Unilateral ultra-brief pulse electroconvulsive therapy for depression in parkinson’s disease. Acta Neurol Scand. doi:10.1111/ane.12614
  • Williams, N. R., Foote, K. D., & Okun, M. S. (2014). STN vs. GPi deep brain stimulation: Translating the rematch into clinical practice. Movement Disorders Clinical Practical (Hoboken), 1, 24–35. doi:10.1002/mdc3.12004
  • Wint, D. P., Okun, M. S., & Fernandez, H. H. (2004). Psychosis in Parkinson’s disease. Journal of Geriatric Psychiatry and Neurology, 17, 127–136. doi:10.1177/0891988704267457
  • Wolters, E. C. (1999). Dopaminomimetic psychosis in Parkinson’s disease patients: Diagnosis and treatment. Neurology, 52, S10–13.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.